Previous Close | 0.7280 |
Open | 0.7380 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.7060 - 0.7380 |
52 Week Range | 0.4030 - 1.0400 |
Volume | |
Avg. Volume | 53,087 |
Market Cap | 213.688M |
Beta (5Y Monthly) | 1.34 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0700 |
Earnings Date | Sep 18, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.90 |
MONTPELLIER, France, November 06, 2024--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announced its participation in upcoming investor conferences to take place in November 2024.
The chip supplier really had a fiscal second quarter to forget.